Adelene Q. Perkins, Director of Bruker BRKR, has filed 0 purchases and 1 sale on the open market. The latest trade was on 02/15.

AP

AP

Adelene Q. Perkins

Director

Company

Bruker BRKR

First filing

23/01/09

Trades

7 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

02/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
IP Infinity Pharmaceuticals	Open-market sale10b5-1 plan	23/09/12	23/09/12	410,196 sh	$0.07	$28,713.72	−25.9%